These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 21969051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.
    Mol Psychiatry; 2014 Apr; 19(4):403-5. PubMed ID: 23752246
    [No Abstract] [Full Text] [Related]

  • 3. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.
    Konte B, Walters JTR, Rujescu D, Legge SE, Pardiñas AF, Cohen D, Pirmohamed M, Tiihonen J, Hartmann AM, Bogers JP, van der Weide J, van der Weide K, Putkonen A, Repo-Tiihonen E, Hallikainen T, Silva E, Ingimarsson O, Sigurdsson E, Kennedy JL, Sullivan PF, Rietschel M, Breen G, Stefansson H, Stefansson K, Collier DA, O'Donovan MC, Giegling I.
    Transl Psychiatry; 2021 Apr 12; 11(1):214. PubMed ID: 33846298
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.
    Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM.
    Pharmacogenomics J; 2015 Oct 12; 15(5):461-6. PubMed ID: 25732907
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J.
    Psychiatr Serv; 1996 Nov 12; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract] [Full Text] [Related]

  • 12. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM, Martin BA, Hu RJ.
    Am J Psychiatry; 2016 Jun 01; 173(6):643. PubMed ID: 27245191
    [No Abstract] [Full Text] [Related]

  • 13. Re: Late-onset neutropenia with clozapine.
    Duggal HS, Singh I.
    Can J Psychiatry; 2006 Feb 01; 51(2):125; author reply 125-6. PubMed ID: 16989111
    [No Abstract] [Full Text] [Related]

  • 14. Genetics of antipsychotic-induced side effects and agranulocytosis.
    Chowdhury NI, Remington G, Kennedy JL.
    Curr Psychiatry Rep; 2011 Apr 01; 13(2):156-65. PubMed ID: 21336863
    [Abstract] [Full Text] [Related]

  • 15. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y, Scholte WF.
    Tijdschr Psychiatr; 2006 Apr 01; 48(4):295-302. PubMed ID: 16955993
    [Abstract] [Full Text] [Related]

  • 16. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Apr 01; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

  • 17. Clozapine-induced agranulocytosis and its genetic determinants.
    Opgen-Rhein C, Dettling M.
    Pharmacogenomics; 2008 Aug 01; 9(8):1101-11. PubMed ID: 18681784
    [Abstract] [Full Text] [Related]

  • 18. Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.
    Dettling M, Cascorbi I, Roots I, Mueller-Oerlinghausen B.
    Arch Gen Psychiatry; 2001 Jan 01; 58(1):93-4. PubMed ID: 11146763
    [No Abstract] [Full Text] [Related]

  • 19. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S.
    J Am Acad Child Adolesc Psychiatry; 2005 Oct 01; 44(10):1024-31. PubMed ID: 16175107
    [Abstract] [Full Text] [Related]

  • 20. Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese Population.
    Saito T, Ikeda M, Hashimoto R, Iwata N, Members of the Clozapine Pharmacogenomics Consortium of Japan are the following, Yamamori H, Yasuda Y, Fujimoto M, Kondo K, Shimasaki A, Kawase K, Miyata M, Mushiroda T, Ozeki T, Kubo M, Fujita K, Kida N, Nakai M, Otsuru T, Fukuji Y, Murakami M, Mizuno K, Shiratsuchi T, Numata S, Ohmori T, Ueno SI, Yada Y, Tanaka S, Kishi Y, Takaki M, Mamoto A, Taniguchi N, Sawa Y, Watanabe H, Noda T, Amano Y, Kimura T, Fukao T, Suwa T, Murai T, Kubota M, Ueda K, Tabuse H, Kanahara N, Kawai N, Nemoto K, Makinodan M, Nishihata Y, Hashimoto N, Kusumi I, Fujii Y, Miyata R, Hirakawa K, Ozaki N.
    Biol Psychiatry; 2017 Jul 01; 82(1):e9-e10. PubMed ID: 28161127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.